Published in N Engl J Med on October 18, 1990
Imported lassa fever in Germany: molecular characterization of a new lassa virus strain. Emerg Infect Dis (2000) 2.69
Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3' to 5' exonuclease activity essential for immune suppression. Proc Natl Acad Sci U S A (2011) 2.12
Historical Lassa fever reports and 30-year clinical update. Emerg Infect Dis (2006) 1.67
Characterization of the interaction of lassa fever virus with its cellular receptor alpha-dystroglycan. J Virol (2005) 1.56
Crystal structure of the Lassa virus nucleoprotein-RNA complex reveals a gating mechanism for RNA binding. Proc Natl Acad Sci U S A (2011) 1.51
Stampidine prevents mortality in an experimental mouse model of viral hemorrhagic fever caused by lassa virus. BMC Infect Dis (2004) 1.45
Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: case report. Virol J (2011) 1.29
Imported Lassa fever, Pennsylvania, USA, 2010. Emerg Infect Dis (2010) 1.28
Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation. PLoS Negl Trop Dis (2012) 1.27
Imported Lassa fever--reexamining the algorithms. N Engl J Med (1990) 1.18
Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report. Virol J (2011) 1.13
Inhibition of the type I interferon antiviral response during arenavirus infection. Viruses (2010) 1.11
Ribavirin for Lassa fever postexposure prophylaxis. Emerg Infect Dis (2010) 0.99
Mapping the zoonotic niche of Lassa fever in Africa. Trans R Soc Trop Med Hyg (2015) 0.98
Using modelling to disentangle the relative contributions of zoonotic and anthroponotic transmission: the case of lassa fever. PLoS Negl Trop Dis (2015) 0.96
Development of live-attenuated arenavirus vaccines based on codon deoptimization. J Virol (2015) 0.91
Envelope exchange for the generation of live-attenuated arenavirus vaccines. PLoS Pathog (2006) 0.91
Lassa fever. BMJ (1991) 0.86
Reverse genetics approaches to combat pathogenic arenaviruses. Antiviral Res (2008) 0.85
Pathogenesis of Lassa fever virus infection: I. Susceptibility of mice to recombinant Lassa Gp/LCMV chimeric virus. Virology (2013) 0.84
Arenavirus reverse genetics for vaccine development. J Gen Virol (2013) 0.83
Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines. J Virol (2015) 0.82
Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitor. J Virol (2013) 0.81
Viral hemorrhagic fevers: advancing the level of treatment. BMC Med (2012) 0.80
Influence of RNA Binding on the Structure and Dynamics of the Lassa Virus Nucleoprotein. Biophys J (2016) 0.76
Reporter-Expressing, Replicating-Competent Recombinant Arenaviruses. Viruses (2016) 0.75
Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein. Virology (2016) 0.75
The enigmatic haemorrhagic fevers. J R Soc Med (1997) 0.75
Reverse Genetics Approaches to Control Arenavirus. Methods Mol Biol (2016) 0.75
The p53 pathway. J Pathol (1999) 6.79
Lassa fever. Effective therapy with ribavirin. N Engl J Med (1986) 6.38
Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med (1999) 5.85
A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis (1987) 5.27
Human asymptomatic Ebola infection and strong inflammatory response. Lancet (2000) 5.20
Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ (1983) 4.81
Cardiac surgery report cards: comprehensive review and statistical critique. Ann Thorac Surg (2001) 4.26
Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among children. Am J Trop Med Hyg (1999) 4.24
Neutrophils in development of multiple organ failure in sepsis. Lancet (2006) 3.64
Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med (1995) 3.60
A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis (1987) 3.51
The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res (1994) 3.28
Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ (1995) 3.21
Clinical virology of Lassa fever in hospitalized patients. J Infect Dis (1987) 2.94
A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J Pathol (1991) 2.71
Descriptive analysis of Ebola virus proteins. Virology (1985) 2.65
The use of SI units in reporting results obtained in hospital laboratories. J Clin Pathol (1974) 2.55
Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis. Lancet (1977) 2.53
Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. Br J Cancer (1991) 2.52
Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. Histopathology (1993) 2.52
Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation. J Clin Microbiol (1982) 2.44
p53 in tumour pathology: can we trust immunohistochemistry?--Revisited! J Pathol (1994) 2.41
Isolated ductus arteriosus aneurysm in the fetus and infant: a multi-institutional experience. J Am Coll Cardiol (2000) 2.36
Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan. Bull World Health Organ (2000) 2.33
The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis. Histopathology (1991) 2.32
Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol (1990) 2.29
The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiol Infect (1997) 2.27
West Nile virus infection in mosquitoes, birds, horses, and humans, Staten Island, New York, 2000. Emerg Infect Dis (2001) 2.16
Pathologic and virologic study of fatal Lassa fever in man. Am J Pathol (1982) 2.14
Ribavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes. Lancet (1984) 2.12
Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect (2006) 2.09
In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol (1993) 2.07
Acute sensorineural deafness in Lassa fever. JAMA (1990) 2.02
Acute abdomen during adjuvant chemotherapy: superior mesenteric artery thrombosis associated with CMF chemotherapy. Clin Oncol (R Coll Radiol) (2001) 2.01
A stable standard suspension for red-cell counts. Lab Pract (1966) 1.96
p53 immunostaining as a marker of malignant disease in diagnostic cytopathology. Lancet (1991) 1.95
Biologic differences between strains of Ebola virus from Zaire and Sudan. J Infect Dis (1983) 1.94
A simple and reliable method for estimating haemoglobin. Bull World Health Organ (1995) 1.94
The effects of different levels of dietary restriction on aging and survival in the Sprague-Dawley rat: implications for chronic studies. Aging (Milano) (2001) 1.93
Junin virus monoclonal antibodies: characterization and cross-reactivity with other arenaviruses. J Gen Virol (1989) 1.92
Family, peer, and neighborhood influences on academic achievement among African-American adolescents: one-year prospective effects. Am J Community Psychol (1996) 1.89
Filoviridae: a taxonomic home for Marburg and Ebola viruses? Intervirology (1982) 1.89
The prohibitin family of mitochondrial proteins regulate replicative lifespan. Curr Biol (1997) 1.86
Pathogenic potential of filoviruses: role of geographic origin of primate host and virus strain. J Infect Dis (1992) 1.84
High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci U S A (1997) 1.81
Quality control in haematology: report of interlaboratory trials in Britain. Br Med J (1969) 1.80
Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables. J Pathol (1987) 1.80
Demand or ideation? Evidence from the Iranian marital fertility decline. Demography (1995) 1.80
Diagnosis of Ebola haemorrhagic fever by RT-PCR in an epidemic setting. J Med Virol (2000) 1.79
Physicochemical inactivation of Lassa, Ebola, and Marburg viruses and effect on clinical laboratory analyses. J Clin Microbiol (1984) 1.78
Primary malignant lymphoma of the colon and rectum. A histopathological and immunohistochemical analysis of 45 cases with clinicopathological correlations. Histopathology (1988) 1.76
Effective vaccine for lassa fever. J Virol (2000) 1.74
The use of 51Cr-labelled heat-damaged red cells to study splenic function. I. Evaluation of method. Br J Haematol (1966) 1.73
Crimean Congo-haemorrhagic fever treated with oral ribavirin. Lancet (1995) 1.72
Progress in laboratory control of oral anticoagulants. Lancet (1982) 1.72
Do we really need a higher necropsy rate? Lancet (1999) 1.71
Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the International Council for Standardization in Haematology. Br J Haematol (1995) 1.70
Monitoring the acute phase response. BMJ (1988) 1.69
Nucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA. Virology (1986) 1.69
Evaluation of the polymerase chain reaction for diagnosis of Lassa virus infection. Am J Trop Med Hyg (1993) 1.66
Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections. Science (1987) 1.66
P nucleotides in V(D)J recombination: a fine-structure analysis. Mol Cell Biol (1993) 1.64
Gadd45 is a nuclear cell cycle regulated protein which interacts with p21Cip1. Oncogene (1995) 1.62
ICSH review of the measurement of the erythocyte sedimentation rate. Int J Lab Hematol (2011) 1.60
Attitudes toward genetic research review: results from a survey of human genetics researchers. Public Health Genomics (2011) 1.58
ESR or CRP? A comparison of their clinical utility. Hematology (2007) 1.58
Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer. J Pathol (1991) 1.58
Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men. Am Heart J (2000) 1.58
Hereditary erythroblastic multinuclearity associated with a positive acidified-serum test: a type of congenital dyserythropoietic anaemia. Br J Haematol (1969) 1.58
Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo. J Cell Sci (1995) 1.57
Wound infection by an indigenous Pseudomonas pseudomallei-like organism isolated from the soil: case report and epidemiologic study. J Infect Dis (1977) 1.57
Mammalian prohibitin proteins respond to mitochondrial stress and decrease during cellular senescence. Exp Cell Res (2001) 1.57
The complexities of proliferating cell nuclear antigen. Histopathology (1992) 1.57
Interobserver agreement in the assessment of parental behavior and parent-adolescent conflict: African American mothers, daughters, and independent observers. Child Dev (1996) 1.56
Cell-cell interactions influence survival and differentiation of purified Purkinje cells in vitro. Neuron (1994) 1.56
Nitric oxide and the control of firefly flashing. Science (2001) 1.56
The haematological complications of polycythaemia vera and treatment with radioactive phosphorus. Br J Radiol (1966) 1.54
'Non-tropical idiopathic splenomegaly' ('primary hypersplenism'): a review of ten cases and their relationship to malignant lymphomas. Br J Haematol (1969) 1.53
Field evaluation of a novel haemoglobin measuring device designed for use in a rural setting. S Afr Med J (1997) 1.53
Human-to-human transmission of Pseudomonas pseudomallei. Ann Intern Med (1975) 1.52
A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. BMJ (1988) 1.51
Reliability of physical examination items used for classification of patients with low back pain. Phys Ther (1998) 1.50
Endocrine cells of the human gastrointestinal tract have no proliferative capacity. Histochem J (1995) 1.49
Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission I. Description of study site, general methodology, and study population. Am J Trop Med Hyg (1999) 1.49
Paroxysmal nocturnal haemoglobinuria. Clin Haematol (1975) 1.49
The epidermal growth factor receptor in human pancreatic cancer. J Pathol (1992) 1.47
Hepatitis G virus in Karachi, Pakistan. Lancet (1996) 1.47
Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. J Clin Pathol (1991) 1.46
Koch's postulates revisited. J Pathol (1991) 1.46
The p53 response to ionising radiation in adult and developing murine tissues. Oncogene (1996) 1.46
Ki67--structure, function, and new antibodies. J Pathol (1992) 1.45
Status of present and candidate international reference preparations (IRP) of thromboplastin for the prothrombin time. A report of the Subcommittee for Control of Anticoagulation. Thromb Haemost (1993) 1.45
Functional characterization of B lymphocytes generated in vitro from embryonic stem cells. Proc Natl Acad Sci U S A (1999) 1.45
Hairpin coding end opening is mediated by RAG1 and RAG2 proteins. Mol Cell (1998) 1.44
APC expression in normal human tissues. J Pathol (1997) 1.44
Circletail, a new mouse mutant with severe neural tube defects: chromosomal localization and interaction with the loop-tail mutation. Genomics (2001) 1.43
Dispersion of neural progenitors within the germinal zones of the forebrain. Nature (1993) 1.43
Stenting for in-stent restenosis: A long-term clinical follow-up. Catheter Cardiovasc Interv (1999) 1.43